1. Home
  2. PLYM vs CSTL Comparison

PLYM vs CSTL Comparison

Compare PLYM & CSTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Plymouth Industrial REIT Inc.

PLYM

Plymouth Industrial REIT Inc.

HOLD

Current Price

$21.93

Market Cap

974.8M

Sector

Real Estate

ML Signal

HOLD

Logo Castle Biosciences Inc.

CSTL

Castle Biosciences Inc.

HOLD

Current Price

$40.07

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PLYM
CSTL
Founded
2011
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
974.8M
1.1B
IPO Year
2017
2019

Fundamental Metrics

Financial Performance
Metric
PLYM
CSTL
Price
$21.93
$40.07
Analyst Decision
Hold
Strong Buy
Analyst Count
8
6
Target Price
$21.14
$43.17
AVG Volume (30 Days)
1.5M
372.4K
Earning Date
02-25-2026
11-03-2025
Dividend Yield
4.38%
N/A
EPS Growth
11196.82
N/A
EPS
2.04
N/A
Revenue
$163,681,000.00
$343,530,000.00
Revenue This Year
$1.88
$1.69
Revenue Next Year
$9.24
N/A
P/E Ratio
$10.76
N/A
Revenue Growth
N/A
10.15
52 Week Low
$12.70
$14.59
52 Week High
$22.74
$42.18

Technical Indicators

Market Signals
Indicator
PLYM
CSTL
Relative Strength Index (RSI) 50.81 62.13
Support Level $21.88 $38.75
Resistance Level $21.94 $39.76
Average True Range (ATR) 0.04 1.34
MACD 0.01 -0.34
Stochastic Oscillator 80.95 54.96

Price Performance

Historical Comparison
PLYM
CSTL

About PLYM Plymouth Industrial REIT Inc.

Plymouth Industrial REIT Inc is a full-service, vertically integrated, self-administered, and self-managed Maryland corporation. It is focused on the acquisition, ownership, and management of single and multi-tenant Class B industrial properties, including distribution centers, warehouses, and light industrial properties, located in secondary and primary markets across the United States. The company has one reportable segment, which is Industrial properties. The majority of its property portfolio is spread across Florida, Ohio, Indiana, Tennessee, Illinois and Georgia, among others. It receives income from the rental revenue through its properties.

About CSTL Castle Biosciences Inc.

Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.

Share on Social Networks: